Your browser doesn't support javascript.
loading
Clinical benefits of serum BNP measurement in patients with chronic kidney disease / 대한내과학회지
Korean Journal of Medicine ; : 135-143, 2005.
Article de Ko | WPRIM | ID: wpr-40857
Bibliothèque responsable: WPRO
ABSTRACT
BACKGROUND: B-type natriuretic peptide (BNP) regulates excretion of water and sodium in the kidney, and serum levels of BNP are increased in the settings of decreased ventricular contractility and myocardial overload. Serum levels of BNP and renal function are important prognostic factors in congestive heart failure, and when renal function deteriorates, BNP level is increased. This study aimed to assess the clinical benefits of BNP measurement in patients with chronic kidney disease (CKD) for prediction of congestive heart failure (CHF). METHODS: Serum levels of BNP were measured in 75 patients with CKD who admitted to Soonchunhyang university Bucheon hospital between the period of April 2003 and April 2004. The clinical data, laboratory findings and echocardiographic findings in these patients were compared retrospectively. RESULTS: The average BNP level of the 75 patients was 1,645.3+/-1,830.9 pg/mL. There were no differences in BNP levels between K/DOQI CKD stages. Levels of BNP were higher in CKD patients with heart failure compared to those without heart failure. BNP levels showed a negative correlation to left ventricular ejection fraction and significant elevation in patients with pulmonary congestion and weight gain on admission. There was no difference in BNP levels in patients with or without left vetricular hypertrophy, and diabetes mellitus. The best cutoff level of BNP for evaluation of heart failure in patients with CKD was 500 pg/mL, with a sensitivity of 78%, specificity of 53%, positive predictive value of 34%, and negative predictive value of 88%, respectively. CONCLUSION: BNP levels showed no difference with the degree of renal failure in patients with CKD, and levels were increased with heart failure in patients with CKD. We discovered though, that in patients with CKD the measurement of serum BNP is a useful factor in assessment of coexisting heart failure, volume status and ischemic heart disease.
Sujet(s)
Mots clés
Texte intégral: 1 Indice: WPRIM Sujet Principal: Sodium / Débit systolique / Échocardiographie / Prise de poids / Études rétrospectives / Sensibilité et spécificité / Ischémie myocardique / Oestrogènes conjugués (USP) / Peptide natriurétique cérébral / Diabète Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies Limites du sujet: Humans langue: Ko Texte intégral: Korean Journal of Medicine Année: 2005 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Sodium / Débit systolique / Échocardiographie / Prise de poids / Études rétrospectives / Sensibilité et spécificité / Ischémie myocardique / Oestrogènes conjugués (USP) / Peptide natriurétique cérébral / Diabète Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies Limites du sujet: Humans langue: Ko Texte intégral: Korean Journal of Medicine Année: 2005 Type: Article